{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T20:05:07Z","timestamp":1790193907614,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006579","name":"Ministry of Industry and Information Technology of the People's Republic of China","doi-asserted-by":"publisher","award":["MCD-2025-2-15"],"award-info":[{"award-number":["MCD-2025-2-15"]}],"id":[{"id":"10.13039\/501100006579","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204087"],"award-info":[{"award-number":["82204087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81973075"],"award-info":[{"award-number":["81973075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82241086"],"award-info":[{"award-number":["82241086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.lfs.2026.124681","type":"journal-article","created":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:32:34Z","timestamp":1789572754000},"page":"124681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Targeting IGF2BP3-driven CSF1\/CSF1R signaling disrupts the positive feedback loop between tumor cells and macrophages and inhibits HCC progression"],"prefix":"10.1016","author":[{"given":"Xiaoying","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linran","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinli","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaxin","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congying","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanli","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangbing","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianke","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunming","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2026.124681_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2026.124681_bb0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2026.124681_bb0015","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.lfs.2026.124681_bb0020","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1097\/HEP.0000000000000237","article-title":"Mechanisms of drug resistance in HCC","volume":"79","author":"Ladd","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.lfs.2026.124681_bb0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1053\/j.gastro.2016.11.048","article-title":"Liver cancer cell of origin, molecular class, and effects on\u202fpatient prognosis","volume":"152","author":"Sia","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.lfs.2026.124681_bb0030","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.ccell.2023.01.010","article-title":"Spatial profiling technologies illuminate the tumor microenvironment","volume":"41","author":"Elhanani","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.lfs.2026.124681_bb0035","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1186\/s12967-023-04716-0","article-title":"Macrophage metabolism, phenotype, function, and therapy in hepatocellular carcinoma (HCC)","volume":"21","author":"Huang","year":"2023","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.lfs.2026.124681_bb0040","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/s41568-022-00547-1","article-title":"A timeline of tumour-associated macrophage biology","volume":"23","author":"Cassetta","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0045","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1158\/0008-5472.CAN-18-1367","article-title":"Diverse functions of macrophages in different tumor microenvironments","volume":"78","author":"Yang","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.lfs.2026.124681_bb0050","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1084\/jem.143.3.631","article-title":"Factors regulating macrophage production and growth: identity of colony-stimulating factor and macrophage growth factor","volume":"143","author":"Stanley","year":"1976","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.lfs.2026.124681_bb0055","doi-asserted-by":"crossref","first-page":"6179","DOI":"10.1073\/pnas.84.17.6179","article-title":"Macrophages specifically regulate the concentration of their own growth factor in the circulation","volume":"84","author":"Bartocci","year":"1987","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124681_bb0060","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1007\/s00262-023-03496-2","article-title":"Blockade of tumor-derived colony-stimulating factor 1 (CSF1) promotes an immune-permissive tumor microenvironment","volume":"72","author":"Maldonado","year":"2023","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.lfs.2026.124681_bb0065","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/nrc1256","article-title":"Tumour-educated macrophages promote tumour progression and metastasis","volume":"4","author":"Pollard","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0070","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrm760","article-title":"Messenger-RNA-binding proteins and the messages they carry","volume":"3","author":"Dreyfuss","year":"2002","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124681_bb0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/nrm.2017.130","article-title":"A brave new world of RNA-binding proteins","volume":"19","author":"Hentze","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124681_bb0080","article-title":"RNA-binding motif proteins as context-dependent regulators of tumor-immune crosstalk, genome stability, and therapeutic vulnerabilities in cancer","volume":"17","author":"Zhang","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.lfs.2026.124681_bb0085","article-title":"The role of RNA binding proteins in cancer biology: a focus on FMRP","volume":"12","author":"Jia","year":"2025","journal-title":"Genes Dis."},{"key":"10.1016\/j.lfs.2026.124681_bb0090","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","article-title":"Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation","volume":"20","author":"Huang","year":"2018","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.lfs.2026.124681_bb0095","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/s41375-021-01346-7","article-title":"The RNA-binding protein IGF2BP3 is critical for MLL-AF4-mediated leukemogenesis","volume":"36","author":"Tran","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.lfs.2026.124681_bb0100","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","article-title":"RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer","volume":"39","author":"Yang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124681_bb0105","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202401399","article-title":"Lactylation-driven IGF2BP3-mediated serine metabolism reprogramming and RNA m6A-modification promotes lenvatinib resistance in HCC","volume":"11","author":"Lu","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.lfs.2026.124681_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.141678","article-title":"Histone acetylation activated-IGF2BP3 regulates cyclin D1 mRNA stability to drive cell cycle transition and tumor progression of hepatocellular carcinoma","volume":"306","author":"Zhou","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2026.124681_bb0115","article-title":"Targeting IGF2BP3 in cancer","volume":"24","author":"Liu","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.lfs.2026.124681_bb0120","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","article-title":"Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential","volume":"11","author":"Zhu","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.lfs.2026.124681_bb0125","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41420-022-01045-x","article-title":"IGF2BP3 enhances the mRNA stability of E2F3 by interacting with LINC00958 to promote endometrial carcinoma progression","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.lfs.2026.124681_bb0130","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2025.288221","article-title":"A small molecule inhibitor of RNA-binding protein IGF2BP3 shows anti-leukemic activity","author":"Jaiswal","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.lfs.2026.124681_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149961","article-title":"Construction of dual functional CuAl-LDHs nanocomposite loaded with IGF2BP3 siRNA for enhanced therapy of gastric cancer","volume":"485","author":"Li","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.lfs.2026.124681_bb0140","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.lfs.2026.124681_bb0145","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1002\/cac2.12345","article-title":"Tumor\u2010associated macrophages in liver cancer: from mechanisms to therapy","volume":"42","author":"Cheng","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.lfs.2026.124681_bb0150","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.lfs.2026.124681_bb0155","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41423-023-01061-6","article-title":"Roles of macrophages in tumor development: a spatiotemporal perspective","volume":"20","author":"Bied","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124681_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.566511","article-title":"Tumor-associated macrophages in human breast, colorectal, lung, ovarian and prostate cancers","volume":"10","author":"Larionova","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.lfs.2026.124681_bb0165","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.lfs.2026.124681_bb0170","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrc1934","article-title":"Hepatocellular carcinoma pathogenesis: from genes to environment","volume":"6","author":"Farazi","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0175","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.jhep.2008.01.008","article-title":"Experimental models of hepatocellular carcinoma","volume":"48","author":"Newell","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2026.124681_bb0180","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.7150\/thno.93115","article-title":"Extracellular vesicles as carriers of mRNA: opportunities and challenges in diagnosis and treatment","volume":"14","author":"Kirian","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.lfs.2026.124681_bb0185","doi-asserted-by":"crossref","first-page":"216","DOI":"10.3748\/wjg.v28.i2.216","article-title":"Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma","volume":"28","author":"Hanif","year":"2022","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.lfs.2026.124681_bb0190","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/modpathol.2008.85","article-title":"Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum","volume":"21","author":"Shafizadeh","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.lfs.2026.124681_bb0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jhep.2023.01.011","article-title":"Identification of a tumour immune barrier in the HCC microenvironment that determines the efficacy of immunotherapy","volume":"78","author":"Liu","year":"2023","journal-title":"J. Hepatol."},{"key":"10.1016\/j.lfs.2026.124681_bb0200","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.trecan.2017.05.003","article-title":"RNA-binding proteins in cancer: old players and new actors","volume":"3","author":"Pereira","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0205","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/nrc2013","article-title":"Cancer as an evolutionary and ecological process","volume":"6","author":"Merlo","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0210","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.lfs.2026.124681_bb0215","first-page":"1308","article-title":"IGF2BP3 enhances the growth of hepatocellular carcinoma tumors by regulating the properties of macrophages and CD8(+) T cells in the tumor microenvironment","volume":"11","author":"Ma","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.lfs.2026.124681_bb0220","doi-asserted-by":"crossref","first-page":"10635","DOI":"10.1007\/s13277-014-2627-0","article-title":"Macrophage colony-stimulating factor and cancer: a review","volume":"35","author":"Chockalingam","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.lfs.2026.124681_bb0225","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41423-020-00541-3","article-title":"Macrophages and the maintenance of homeostasis","volume":"18","author":"Mosser","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.lfs.2026.124681_bb0230","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.biopha.2018.04.046","article-title":"Recent advances in colony stimulating factor-1 receptor\/c-FMS as an emerging target for various therapeutic implications","volume":"103","author":"Kumari","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.lfs.2026.124681_bb0235","doi-asserted-by":"crossref","first-page":"363","DOI":"10.3389\/fcell.2019.00363","article-title":"IGF2BP3 from physiology to cancer: novel discoveries, unsolved issues, and future perspectives","volume":"7","author":"Mancarella","year":"2020","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.lfs.2026.124681_bb0240","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1476-4598-11-58","article-title":"Regulation of colony stimulating factor-1 expression and ovarian cancer cell behavior in vitro by miR-128 and miR-152","volume":"11","author":"Woo","year":"2012","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.lfs.2026.124681_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2024.123059","article-title":"Unconventional p65\/p52 NF-\u03baB module regulates key tumor microenvironment-related genes in breast tumor-associated macrophages (TAMs)","volume":"357","author":"De Paolis","year":"2024","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2026.124681_bb0250","doi-asserted-by":"crossref","first-page":"E2120","DOI":"10.1073\/pnas.1406655111","article-title":"Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment","volume":"111","author":"Chaturvedi","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.lfs.2026.124681_bb0255","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1182\/bloodadvances.2023011132","article-title":"Targeting IGF2BP3 enhances antileukemic effects of menin-MLL inhibition in MLL-AF4 leukemia","volume":"8","author":"Lin","year":"2024","journal-title":"Blood Adv."},{"key":"10.1016\/j.lfs.2026.124681_bb0260","first-page":"4888","article-title":"Small-molecule exhibits anti-tumor activity by targeting the RNA m(6)A reader IGF2BP3 in ovarian cancer","volume":"13","author":"Shu","year":"2023","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.lfs.2026.124681_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.149961","article-title":"Construction of dual functional CuAl-LDHs nanocomposite loaded with IGF2BP3 siRNA for enhanced therapy of gastric cancer","volume":"485","author":"Li","year":"2024","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.lfs.2026.124681_bb0270","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2026849118","article-title":"Combining CD47 blockade with trastuzumab eliminates HER2-positive breast cancer cells and overcomes trastuzumab tolerance","volume":"118","author":"Upton","year":"2021","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.lfs.2026.124681_bb0275","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.surg.2023.05.011","article-title":"Pressure-Enabled Drug Delivery (PEDD) of a class C TLR9 agonist in combination with checkpoint inhibitor therapy in a murine pancreatic cancer model","volume":"174","author":"Capacio","year":"2023","journal-title":"Surgery"}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052600490X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002432052600490X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T19:38:11Z","timestamp":1790192291000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002432052600490X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":55,"alternative-id":["S002432052600490X"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124681","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting IGF2BP3-driven CSF1\/CSF1R signaling disrupts the positive feedback loop between tumor cells and macrophages and inhibits HCC progression","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2026.124681","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"124681"}}